Status:

TERMINATED

Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks

Lead Sponsor:

Assistance Publique Hopitaux De Marseille

Conditions:

Cluster Headache

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Cluster headache is characterized by unilateral excruciating head pain and autonomic dysfunction. Hypothalamic overactivity was observed in nitrate-induced cluster-headache and in only one case of spo...

Eligibility Criteria

Inclusion

  • cluster headache in crisis
  • no serious illnesses in progress as cancer, autoimmune disease, liver disease
  • patient without chronic psychiatric disease excluding moderate and reactional depression
  • no demential disease
  • no anxious or depressive disease
  • no contraindication to PET scan (pregnancy and breast-feeding)
  • social security cover
  • written informed consent

Exclusion

  • No effective contraception taken
  • unable to realize a decubitus of 15 minutes long

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2011

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT00458770

Start Date

May 1 2009

End Date

May 1 2011

Last Update

February 25 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pôle de Neurosciences Cliniques CHU Timone

Marseille, France, 13005

Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks | DecenTrialz